GALLANT 6 Tesaglitazar vs. Pioglitazone

Clinical trial NCT00214565 · TERMINATED

Trial details

NCT number: NCT00214565
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2004-08-01
Primary completion: 2006-10-01
Enrollment: 1450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.